{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:57:04Z","timestamp":1790758624447,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012161","name":"The University of British Columbia Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012161","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.humpath.2023.09.006","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T16:41:40Z","timestamp":1695919300000},"page":"64-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma"],"prefix":"10.1016","volume":"141","author":[{"given":"Derek M.","family":"van Pel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana N.","family":"Ionescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4851-8517","authenticated-orcid":false,"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2023.09.006_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2023.09.006_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/his.14783","article-title":"Hypothesis: HEG1 and claudin-4 staining will allow a diagnosis of epithelioid and biphasic mesothelioma versus non-small-cell lung carcinoma with only two stains in most cases","volume":"82","author":"Churg","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2023.09.006_bib3","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1083\/jcb.111.3.1207","article-title":"Uroplakin I: a 27-kD protein associated with the asymmetric unit membrane of mammalian urothelium","volume":"111","author":"Yu","year":"1990","journal-title":"J Cell Biol"},{"key":"10.1016\/j.humpath.2023.09.006_bib4","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1242\/jcs.00811","article-title":"Structural basis of urothelial permeability barrier function as revealed by Cryo-EM studies of the 16 nm uroplakin particle","volume":"116","author":"Min","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.humpath.2023.09.006_bib5","first-page":"963","article-title":"Genetic detection for hematogenous micrometastasis in patients with various types of malignant tumors using Uroplakin II derived primers in polymerase chain reaction","volume":"10","author":"Hirata","year":"2003","journal-title":"Oncol Rep"},{"key":"10.1016\/j.humpath.2023.09.006_bib6","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/diagnostics12102516","article-title":"Analysis of more than 16,000 human tumor and normal tissues identifies uroplakin 3B as a useful diagnostic marker for mesothelioma and normal mesothelial cells","volume":"12","author":"Lennartz","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.humpath.2023.09.006_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/PAI.0000000000001072","article-title":"Distinct uroplakin II staining pattern in apocrine breast carcinoma","volume":"30","author":"van Pel","year":"2022","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2023.09.006_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00129039-200409000-00010","article-title":"P63 expression in lung carcinoma: a tissue microarray study of 408 cases","volume":"12","author":"Au","year":"2004","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2023.09.006_bib9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/PAS.0000000000001469","article-title":"HEG1 is a highly specific and sensitive marker of epithelioid malignant mesothelioma","volume":"44","author":"Naso","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.09.006_bib10","article-title":"New developments in mesothelial pathology","author":"Churg","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2023.09.006_bib11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/PAS.0000000000001712","article-title":"Utility of SOX6 and DAB2 for the diagnosis of malignant mesothelioma","volume":"45","author":"Naso","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.09.006_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/diagnostics13020249","article-title":"Immunohistochemistry for claudin-4 and BAP1 in the differential diagnosis between sarcomatoid carcinoma and sarcomatoid mesothelioma","volume":"13","author":"Zuccatosta","year":"2023","journal-title":"Diagnostics (Basel)"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723001995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723001995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:41:51Z","timestamp":1758645711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817723001995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":12,"alternative-id":["S0046817723001995"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2023.09.006","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2023.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}